EPHB4 and neoplasm: From the missing effects of a continuous oral administration of ‘NVP’ following the protocol published by Martiny-Baron et al. [16], we concluded in 2018 that EphB4-induced ephrinB2 reverse signaling is responsible for the observed effects on tumor growth, perfusion, and hypoxia [29].